The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer.
Tanaka N.
Prostate Int. 2023 Sep;11(3):127-133. doi: 10.1016/j.prnil.2023.01.004. Epub 2023 Feb 6.
PMID:37745911
Relapse patterns after low-dose-rate prostate brachytherapy.
Lamb DS, Greig L, FitzJohn T, Russell GL, Nacey JN, Iupati D, Woods L.
Brachytherapy. 2021 Mar-Apr;20(2):291-295. doi: 10.1016/j.brachy.2020.09.013. Epub 2020 Nov 3.
PMID:33158775
High Dose Rate Brachytherapy versus Low Dose Rate Brachytherapy for the Treatment of Prostate Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness.
Gray C, Campbell K.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 14.